Reply to comment on: Optical coherence tomography angiography in central serous chorioretinopathy treated with oral eplerenone and half-fluence photodynamic therapy: A comparative study
Restricted accessLetterFirst published online May, 2024
Reply to comment on: Optical coherence tomography angiography in central serous chorioretinopathy treated with oral eplerenone and half-fluence photodynamic therapy: A comparative study
ClementeLCennamoGMontorioD, et al.OCT-A in chronic central serous chorioretinopathy treated with oral eplerenone and half-fluence photodynamic therapy: a comparative study. Eur J Ophthalmol2022 Oct 9: 11206721221131129.
2.
IovinoCPellegriniMBernabeiF, et al.Choroidal vascularity index: an in-depth analysis of this novel optical coherence tomography parameter. J Clin Med2020 Feb 21; 9: 595.
3.
TanKAGuptaPAgarwalA, et al.State of science: choroidal thickness and systemic health. Surv Ophthalmol2016; 61: 566–581.
4.
TanCSOuyangYRuizH,et al.Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci2012; 53: 261–266.
5.
ToyokawaNKimuraHFukomotoA,et al.Difference in morning and evening choroidal thickness in Japanese subjects with no chorioretinal disease. Ophthalmic Surg Lasers Imaging2012; 43: 109–114.
